Apple Inc. v. Varia Holdings LLC

IPR2024-01364

Apple Inc.'s IPR challenge against Varia Holdings LLC regarding RFID/Bluetooth integration has been instituted by the PTAB. The Board found sufficient grounds to proceed, focusing on obviousness over prior art combining Bluetooth transceivers and headsets.

Jurisdiction
US PTAB
Case Number
IPR2024-01364
Filing Date
30 August 2024
Outcome
instituted

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Apple Inc. vs Varia Holdings LLC is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patentIPR2024-00981

Kia Corporation et al.vsEmerging Automotive LLC

The PTAB issued a Final Written Decision finding all 20 claims of the '188 patent unpatentable based on obviousness (35 U.S.C. § 103). The Petitioner successfully demonstrated that independent claim 1 and dependent claims were rendered obvious by combining Kleve with Sekiyama, while other claims were found obvious in view of various combinations including Kleve/Mottla and Zaid/Harris.

patentIPR2025-00717

PacifiCorp et al.vsMES, Inc.

The Director granted review of institution decisions in an IPR case, vacating the initial rulings and remanding the matter to the Board. The decision addressed the issue of multiple petitions challenging a single patent.

patentPGR2024-00035

MPL Brands NV, Inc.vsBuzzBallz, LLC

MPL Brands NV successfully convinced the PTAB that all 20 claimed claims of the patent were unpatentable. The Board found obviousness over multiple prior art references, including PCAN, Metzger, and Kaminski, in a final decision.

patentIPR2024-01077

Samsung Electronics Co., Ltd. et al.vsOura Health Oy et al.

The PTAB issued a Final Written Decision rejecting all grounds of obviousness (35 U.S.C. § 103) against the smart ring patent. The Board upheld the validity of the claims, finding that the combination of prior art references required non-obvious structural overhauls and lacked proper nexus to the claimed invention.

patentIPR2024-00622

Merck Sharp & Dohme LLC et al.vsThe Johns Hopkins University

Merck Sharp & Dohme LLC successfully convinced the PTAB to institute IPR proceedings against The Johns Hopkins University regarding anti-cancer therapies using PD-1 blockade. The Board found sufficient evidence that prior art, including the MSI-H Study Record, renders several claims unpatentable.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call